EverHint Signal — EMA10 × SMA50 Crossover - November 25, 2025
EMA10 × SMA50 generated 18 Buy signals and 22 Sell signals today. Buys sit mostly in the 58–71 RSI band with strengthening short-term momentum, while Sells remain deeply oversold across tech, industrial, and growth names. Market tone was broadly risk-on with VIX falling.
What This Signal Is (Quick)
The EMA10 × SMA50 crossover looks for shifts in short-term vs. medium-term momentum:
- Buy (EMA10 > SMA50)
Fast trend overtakes the slower trend — early bullish inflection. - Sell (EMA10 < SMA50)
Fast trend weakens below the medium-term trend — early warning of deterioration.
Why this matters:
- EMA10 reacts fast → captures turns early.
- SMA50 is stable → filters noise.
- Together, they identify transitions that swing traders often anticipate 3–15 days ahead.
As always, this is an experimental scanner designed for research and idea generation.
How Today’s Signals Are Ranked
Per EverHint rules:
- When ranking is not explicitly specified, default = RSI(14) ascending.
- Lower RSI → earlier stage of momentum shift.
- Buys and Sells are ranked independently.
Overlays included:
- Insider Net (P vs. S over last 90 days)
- Days → Earnings (bmo / amc if present)
- Liquidity (20-day average dollar volume)
- Sector exposure
- Price level & trend context
📈 All BUY Signals — Sorted by RSI(14)
(Lower RSI = earlier/cleaner transition into bullish momentum)
Total Buy signals today: 18
| Rank | Ticker | Company | Sector | Last ($) | RSI(14) | M.Cap | Insider Net | Days → Earnings | Liquidity (20d $) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AMKR | Amkor Technology | Technology | 37.91 | 58.3 | 9.8B | $0 | 77 (amc) | 128.7M |
| 2 | EXAS | Exact Sciences | Healthcare | 100.90 | 58.8 | 19.1B | −$1.3M | 86 (amc) | 700.9M |
| 3 | ARE | Alexandria Real Estate | Real Estate | 115.24 | 58.8 | 19.8B | $0 | 76 (amc) | 144.0M |
| 4 | BMRN | BioMarin Pharmaceutical | Healthcare | 55.50 | 58.8 | 10.7B | $0 | 64 (amc) | 177.6M |
| 5 | OTIS | Otis Worldwide | Industrials | 95.80 | 65.0 | 38.9B | $0 | 81 (bmo) | 227.4M |
| 6 | HUBS | HubSpot | Technology | 597.92 | 65.8 | 29.8B | +$221.3K | 78 (bmo) | 991.7M |
| 7 | ERIE | Erie Indemnity | Financial Services | 441.36 | 66.1 | 21.4B | +$511.9K | 72 (amc) | 45.1M |
| 8 | APG | APi Group | Industrials | 34.59 | 66.3 | 8.0B | $0 | 61 (bmo) | 52.2M |
| 9 | XLF | Financial Select Sector SPDR | Financials | 43.22 | 67.1 | — | — | — | 2.7B |
| 10 | CWEN | Clearway Energy | Utilities | 27.65 | 67.4 | 6.2B | +$54.3K | 70 (bmo) | 63.0M |
Buy-side profile
- RSI levels cluster between 58–67, signaling early-to-mid bullish transitions, not overextended surges.
- EXAS shows heavy insider selling (–$1.3M), the only negative divergence among top Buy names.
- Sector tilt: Healthcare + Industrials + Technology leading the bullish cohort.
- Liquidity across the board is healthy → reduces slippage risk.
📉 All SELL Signals — Sorted by RSI(14)
(Lower RSI = deeper selling pressure under a fresh bearish reversal)
Total Sell signals today: 22
| Rank | Ticker | Company | Sector | Last ($) | RSI(14) | M.Cap | Insider Net | Days → Earnings | Liquidity (20d $) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | QS | QuantumScape | Consumer Cyclical | 11.86 | 15.1 | 7.1B | −$21.0M | 78 (amc) | 502.9M |
| 2 | EQIX | Equinix | Real Estate | 748.15 | 16.9 | 73.0B | −$312K | 78 (amc) | 431.1M |
| 3 | CORZ | Core Scientific | Technology | 15.55 | 17.3 | 4.8B | $0 | — | 338.2M |
| 4 | CYBR | CyberArk | Technology | 447.45 | 21.9 | 22.6B | $0 | 79 (bmo) | 200.2M |
| 5 | APLD | Applied Digital | Technology | 23.74 | 22.9 | 6.6B | −$18.4M | 49 (bmo) | 743.2M |
| 6 | PEGA | Pegasystems | Technology | 54.48 | 28.1 | 9.3B | −$4.8M | 78 (amc) | 65.5M |
| 7 | BWXT | BWX Technologies | Industrials | 175.26 | 29.4 | 16.0B | $0 | 90 (amc) | 270.0M |
| 8 | IBKR | Interactive Brokers | Financial Services | 63.17 | 30.3 | 109B | −$3.1M | 56 (amc) | 282.3M |
| 9 | NET | Cloudflare | Technology | 197.49 | 31.2 | 69.2B | −$7.5M | 72 (amc) | 799.5M |
| 10 | PLTR | Palantir | Technology | 163.55 | 35.3 | 373.6B | −$12.8M | 69 (amc) | 11.4B |
Sell-side profile
- RSI cluster 15–35 → deep selling in growth, tech, and high-beta names.
- Heavy insider selling concentrated in QS, APLD, PLTR, NET amplifies bearish conviction.
- EQIX (RSI 16.9) stands out as a rare large-cap REIT with a meaningful Sell signal.
Recent Headlines (Summaries)
- QS — Several analysts highlight the stock’s volatility due to uncertainties around long-duration battery commercialization.
- CYBR — Coverage notes sustained demand for identity and access-security solutions despite pressure in broader cybersecurity names.
- NET — Mixed commentary: long-term cloud adoption tailwinds vs. near-term margin compression concerns.
- EXAS — Reports highlight continued adoption of non-invasive testing platforms, though growth pacing varies by segment.
- APLD / CORZ — Miner and data-center-linked plays see volatility tied to energy costs and crypto price swings.
Market Backdrop — November 25, 2025
Indices were solidly green:
- S&P 500: +1.03%
- Dow Jones: +1.36%
- Nasdaq: +0.98%
- Russell 2000: +2.00% (small-caps leading)
Risk metrics:
- VIX: 18.56 (–9.7%) → easing vol
- 10-year yield: ~4.0% → supportive for growth
Crypto:
- BTC: −1.33%
- ETH: −0.57%
Interpretation:
Risk-on tone in equities with broad participation, but not fully mirrored in crypto. Falling VIX enhances the reliability of EMA-based momentum signals.
Vlad’s Take (EverHint)
- Buy signals today look like true early-trend continuation, not late-stage breakouts.
- The Sell list has much deeper RSI compression, especially in high-beta growth, which often marks forced de-risking.
- Insider flows reinforce trends: strong selling pressure among Sell names signals persistence rather than noise.
- Given the improving market background, Buy signals appear more actionable on a 3–7 day swing horizon, while Sells are best used as risk-off markers or watchlist names for future reversals.
EMA10 × SMA50 is best treated as an early-momentum alert system, especially when paired with rising market breadth and falling volatility — both present today.
Independent, data-driven signals.
No hype. No promotions. Just experimental breakout research from EverHint.
This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/
and https://www.everhint.com/faqs/